Purinergic P2X 4 receptor: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (→See also: fix) |
Notjusttired (talk | contribs) m (Text replacement - "date = " to "date = ") |
||
| (60 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
'''Purinergic 2X 4 receptor''' or '''purinergic receptor P2 X, ligand-gated ion channel 4''' or '''P2X4''' or '''P2RX4'''. | '''Purinergic 2X 4 receptor''' or '''purinergic receptor P2 X, ligand-gated ion channel 4''' or '''P2XR4''' or '''P2X4''' or '''P2RX4'''.<ref name="genecards">{{Cite web|access-date=2022-04-07 | url=https://www.genecards.org/cgi-bin/carddisp.pl?gene=P2RX4 | title = P2RX4 Protein {{!}} P2RX4 Antibody | ||
|website=Gene cards}}</ref> | |||
==Function== | ==Function== | ||
| Line 7: | Line 8: | ||
==Notable studies == | ==Notable studies == | ||
*2016, Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample<ref name="Iacob2016">{{Cite journal|title=Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample|date=Jan 2016|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684820/|journal=Arthritis care & research|volume=68|issue=1|pages=132–140|last=Iacob|first=Eli|author-link=|last2=Light|first2=Alan R.| | *2016, Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample<ref name="Iacob2016">{{Cite journal | title = Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample | date = Jan 2016|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684820/|journal=Arthritis care & research|volume=68|issue=1|pages=132–140 | last = Iacob | first = Eli | author-link = | last2 = Light | first2 = Alan R. | authorlink2 = Alan Light | last3 = Donaldson | first3 = Gary W. | authorlink3 = | last4 = Okifuji | first4 = Akiko | authorlink4 = | last5 = Hughen | first5 = Ronald W. | authorlink5 = | last6 = White | first6 = Andrea T. | authorlink6 = Andrea White | last7 = Light | first7 = Kathleen C. | authorlink7 = Kathleen Light|doi=10.1002/acr.22639|pmc=4684820|pmid=26097208|access-date=|issn=2151-464X|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684820/ (Full text)] | ||
*2012, Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome<ref name="Light2012Stress">{{Cite journal | last1 = Light | first1 = KC | authorlink = Kathleen Light | last2 = White | first2 = AT | authorlink2 = Andrea White | last3 = Tadler | first3 =S | last4 = Iacob | first4 = E| last5 = Light | first5 = Alan R | authorlink5 = Alan Light | url= https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200121/ | title = Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome |journal=Pain Research and Treatment | date = 2012 | page = 427869 | pmc = PMC3200121 |doi= 10.1155/2012/427869}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200121/ (Full text)] | |||
*2012, Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with [[multiple sclerosis]], and healthy controls<ref name="White2012">{{Cite journal | last1 = White | first1 = AT | authorlink1 = Andrea White | last2 = Light | first2 = AR | authorlink2 = Alan Light | last3 = Hughen | first3 = RW | authorlink3 = | last4 = Vanhaitsma | first4 = TA | authorlink4 = | last5 = Light | first5 = KC | authorlink5 = Kathleen Light| title = Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls| journal = Psychosomatic Medicine | volume = 74 | issue = 1 | page = 46-54 | date = 2012| pmid = | pmc = PMC3256093| url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256093/| doi = 10.1097/PSY.0b013e31824152ed}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256093/ (Full text)] | |||
*2012, Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome<ref name="Light2012FM">{{Cite journal | last1 = Light | first1 = Alan R | authorlink1 = Alan Light | last2 = Bateman | first2 = Lucinda | authorlink2 = Lucinda Bateman | last3 = Jo | first3 = Daehyun | authorlink3 = Daehyun Jo | last4 = Hughen | first4 = Ronald W | authorlink4 = | last5 = Vanhaitsma | first5 = Timothy A | authorlink5 = | last6 = White | first6 = AT | authorlink6 = Andrea White | last7 = Light | first7 = Kathleen | authorlink7 = Kathleen Light| title = Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome| journal = Journal of Internal Medicine | volume = 271 | issue = 1 | page = 64-81 | date = 2012| pmid = | pmc = PMC3175315 | doi = 10.1111/j.1365-2796.2011.02405.x | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175315/ }}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175315/ (Full Text)] | |||
==See also == | ==See also == | ||
*[[Transient receptor potential vanilloid receptor 1]] | *[[Transient receptor potential vanilloid receptor 1]] | ||
*[[Purinergic | *[[Purinergic P2X 5 receptor]] | ||
*[[Acid sensing ion channel 3]] | *[[Acid sensing ion channel 3]] | ||
*[[Post-exertional malaise]] | *[[Post-exertional malaise]] | ||
*[[Genetics of chronic fatigue syndrome]] | |||
==Learn more == | ==Learn more == | ||
*[https://www.genecards.org/cgi-bin/carddisp.pl?gene=P2RX4 P2RX4 Protein {{!}} P2RX4 Antibody] - Gene card | |||
==References == | ==References == | ||
| Line 25: | Line 31: | ||
[[Category:Energy system]] | [[Category:Energy system]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Proteins]] | |||
[[Category:Antibodies]] | |||
Latest revision as of 05:52, April 2, 2023
 | This article is a stub. |
Purinergic 2X 4 receptor or purinergic receptor P2 X, ligand-gated ion channel 4 or P2XR4 or P2X4 or P2RX4.[1]
Function[edit | edit source]
ME/CFS[edit | edit source]
Notable studies[edit | edit source]
- 2016, Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample[2] - (Full text)
- 2012, Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome[3] (Full text)
- 2012, Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls[4] (Full text)
- 2012, Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome[5] (Full Text)
See also[edit | edit source]
- Transient receptor potential vanilloid receptor 1
- Purinergic P2X 5 receptor
- Acid sensing ion channel 3
- Post-exertional malaise
- Genetics of chronic fatigue syndrome
Learn more[edit | edit source]
- P2RX4 Protein | P2RX4 Antibody - Gene card
References[edit | edit source]
- ↑ "P2RX4 Protein | P2RX4 Antibody". Gene cards. Retrieved April 7, 2022.
- ↑ Iacob, Eli; Light, Alan R.; Donaldson, Gary W.; Okifuji, Akiko; Hughen, Ronald W.; White, Andrea T.; Light, Kathleen C. (January 2016). "Gene expression factor analysis to differentiate pathways linked to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample". Arthritis care & research. 68 (1): 132–140. doi:10.1002/acr.22639. ISSN 2151-464X. PMC 4684820. PMID 26097208.
- ↑ Light, KC; White, AT; Tadler, S; Iacob, E; Light, Alan R (2012). "Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome". Pain Research and Treatment: 427869. doi:10.1155/2012/427869. PMC 3200121.
- ↑ White, AT; Light, AR; Hughen, RW; Vanhaitsma, TA; Light, KC (2012). "Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls". Psychosomatic Medicine. 74 (1): 46-54. doi:10.1097/PSY.0b013e31824152ed. PMC 3256093.
- ↑ Light, Alan R; Bateman, Lucinda; Jo, Daehyun; Hughen, Ronald W; Vanhaitsma, Timothy A; White, AT; Light, Kathleen (2012). "Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome". Journal of Internal Medicine. 271 (1): 64-81. doi:10.1111/j.1365-2796.2011.02405.x. PMC 3175315.
